Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation. [electronic resource]
Producer: 20171229Description: 962-968 p. digitalISSN:- 1090-2104
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Mice
- Mice, Inbred C57BL
- Pancreatic Neoplasms -- drug therapy
- Peptide Fragments -- administration & dosage
- Protein Kinase C -- administration & dosage
- T-Lymphocytes -- drug effects
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.